Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuron

• Publication date

  2008-12-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuron.2008.10.047PMID 19109907PMCID PMC2667382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

  2009cited by this paper
• The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

  2008influential reference
• Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload.

  2008cited by this paper
• Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing.

  2008cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008influential reference
• Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease

  2007cited by this paper
• Early detection of Alzheimer's disease using neuroimaging.

  2007cited by this paper
• Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5′ untranslated region

  2007influential reference
• Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

  2007cited by this paper
• Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.

  2007influential reference
• Spatial and temporal control of age-related APP processing in genomic-based beta-secretase transgenic mice.

  2007cited by this paper
• Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders

  2007cited by this paper
• The endoplasmic reticulum and the unfolded protein response.

  2007cited by this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007influential reference
• Leaky Scanning and Reinitiation Regulate BACE1 Gene Expression

  2006influential reference
• BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation

  2006cited by this paper
• Phosphorylation of the alpha subunit of translation initiation factor-2 by PKR mediates protein synthesis inhibition in the mouse brain during status epilepticus.

  2006cited by this paper
• Cytoskeletal and cell contact control of the glucocorticoid pathway.

  2006cited by this paper
• Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

  2006cited by this paper
• p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β In Vivo

  2006cited by this paper
• The cytoskeletal network controls c-Jun translation in a UTR-dependent manner

  2006cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006cited by this paper
• Divergent roles of IRE1alpha and PERK in the unfolded protein response.

  2006cited by this paper
• Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1

  2006cited by this paper
• Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes

  2006cited by this paper
• Divergent Roles of IRE1α and PERK in the Unfolded Protein Response

  2006influential reference
• The unfolded protein response

  2006cited by this paper
• BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo

  2005cited by this paper
• Cognitive status correlates with neuropathologic stage in Parkinson disease

  2005cited by this paper
• Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease--therapeutic potential.

  2005cited by this paper
• BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions

  2005cited by this paper
• eIF2B, a mediator of general and gene-specific translational control.

  2005influential reference
• Translational control of hippocampal synaptic plasticity and memory by the eIF2α kinase GCN2

  2005cited by this paper
• Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

  2005cited by this paper
• Translational control in stress and apoptosis

  2005cited by this paper
• A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.

  2005cited by this paper
• A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress

  2005influential reference
• β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways

  2005cited by this paper
• Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.

  2005influential reference
• Traumatic brain injury: cause or risk of Alzheimer’s disease? A review of experimental studies

  2005cited by this paper
• Amyloid precursor protein (APP) and its derivatives change after cellular energy depletion. An in vitro-study

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• BACE Is Degraded via the Lysosomal Pathway*

  2005cited by this paper
• Vascular factors in dementia: an overview.

  2004cited by this paper
• Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation.

  2004cited by this paper
• Phosphorylation of eIF2alpha is involved in the signaling of indispensable amino acid deficiency in the anterior piriform cortex of the brain in rats.

  2004cited by this paper
• The Epidemiology of the Comorbidity of Epilepsy in the General Population

  2004cited by this paper
• Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

  2004cited by this paper
• Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer’s disease β-secretase (BACE-1)

  2004cited by this paper
• BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease.

  2004cited by this paper
• β‐secretase‐cleaved amyloid precursor protein in Alzheimer brain: a morphologic study

  2004cited by this paper
• Expression of the Alzheimer protease BACE1 is suppressed via its 5'‐untranslated region

  2004influential reference
• Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.

  2004cited by this paper
• Synaptic plasticity and translation initiation.

  2004cited by this paper
• beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice.

  2004cited by this paper
• Increased beta-secretase activity and expression in rats following transient cerebral ischemia.

  2004cited by this paper
• Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.

  2004cited by this paper
• Degradation of BACE by the ubiquitin‐proteasome pathway

  2004cited by this paper
• Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.

  2004cited by this paper
• Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology

  2004cited by this paper
• Gene structure and organization of the human beta-secretase (BACE) promoter.

  2004cited by this paper
• Increased β-secretase activity and expression in rats following transient cerebral ischemia

  2004cited by this paper
• Gene structure and organization of the human β‐secretase (BACE) promoter

  2004cited by this paper
• Translational regulation of BACE-1 expression in neuronal and non-neuronal cells.

  2004cited by this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Increases Amyloid Deposition in Brain Parenchyma but Reduces Cerebrovascular Amyloid Angiopathy in Aging BACE × APP[V717I] Double-Transgenic Mice

  2004cited by this paper
• Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients

  2004cited by this paper
• Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

  2003cited by this paper
• Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice.

  2003cited by this paper
• Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

  2003cited by this paper
• Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex.

  2003cited by this paper
• Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

  2003influential reference
• APP processing and synaptic function.

  2003cited by this paper
• A critical discussion of the role of neuroimaging in mild cognitive impairment *

  2003cited by this paper
• Inhibition of a constitutive translation initiation factor 2α phosphatase, CReP, promotes survival of stressed cells

  2003cited by this paper
• Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

  2002cited by this paper
• alpha- and beta-secretase: profound changes in Alzheimer's disease.

  2002cited by this paper
• Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?

  2002cited by this paper
• Expression of human β‐secretase in the mouse brain increases the steady‐state level of β‐amyloid

  2002cited by this paper
• γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?

  2002cited by this paper
• Control of PERK eIF2α kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK

  2002cited by this paper
• Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease

  2002cited by this paper
• Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

  2002cited by this paper
• Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

  2001cited by this paper
• Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

  2001cited by this paper
• Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α

  2001cited by this paper
• Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival.

  2001cited by this paper
• Regulation of eukaryotic initiation factor eIF2B.

  2001cited by this paper
• Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production.

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

  2001cited by this paper
• Initiation Factor eIF2α Phosphorylation in Stress Responses and Apoptosis

  2001influential reference
• The glucose-regulated proteins: stress induction and clinical applications.

  2001cited by this paper
• Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis.

  2001cited by this paper
• Oxidant Stress Stimulates Phosphorylation of eIF4E without an Effect on Global Protein Synthesis in Smooth Muscle Cells

  2000cited by this paper
• Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties.

  2000cited by this paper
• Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase.

  2000cited by this paper
• Characterization of Alzheimer's β-Secretase Protein BACE

  2000influential reference
• A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha.

  2000cited by this paper
• Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme

  2000cited by this paper

• How Do Amyloid Pathology and Aberrant Neuronal Activity Disrupt Plasticity and Memory in Alzheimer’s Disease?

  2026cites this paper
• Isoform-specific roles and overlooked complexity of AMPKα in Alzheimer's disease

  2026cites this paper
• RNA-binding activity of PHGDH drives amyloid-beta production in a human brain organoid model of sporadic Alzheimer's disease.

  2026cites this paper
• AMPKα2 signals amino acid insufficiency to inhibit protein synthesis.

  2025cites this paper
• Targeting Both Monomer and Oligomer with Fibrinogen Efficiently Suppresses Amyloid Fibril Formation and Cell Toxicity of Amyloid β 1‑42

  2025cites this paper
• Predicting cellular adaptation proteins dependent on eIF2α regulation under stress conditions: Physiological and pathophysiological implications in neuronal function

  2025cites this paper
• Exploring the effects of squalene in the PERK/ATF4/eIF2α/CHOP signalling pathway in an in vitro Alzheimer Disease model and insilico approach

  2025cites this paper
• Protein Misfolding and Aggregation in the Pathogenesis of Alzheimer’s Disease

  2025cites this paper
• Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

  2025cites this paper
• Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression

  2025cites this paper
• Organelle abnormalities in Alzheimer's disease.

  2025cites this paper
• Dual Nature of Mitochondrial Integrated Stress Response: Molecular Switches from Protection to Pathology

  2025cites this paper
• Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure

  2025cites this paper
• Key considerations for ELISA-based quantification of diverse amyloid beta forms in murine brain homogenates

  2025cites this paper
• BACE1-dependent cleavage of GABAA receptor contributes to neural hyperexcitability and disease progression in Alzheimer's disease.

  2025cites this paper
• Chaperone-Mediated Responses and Mitochondrial–Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer’s Disease

  2025cites this paper
• eIF2Bε phosphorylation activates integrated stress response-mediated protein translation and links stress signalling to amyloidogenesis in Alzheimer’s disease

  2025cites this paper
• Impaired insulin signaling and diet-induced type 3 diabetes pathophysiology increase amyloid β expression in the Drosophila model of Alzheimer's disease.

  2024cites this paper
• Therapeutic Efficacy of Extracellular Vesicles Derived from Stem Cell for Alzheimer's Disease: A Meta-Analysis Study.

  2024cites this paper
• Epileptic seizures induced by pentylenetetrazole kindling accelerate Alzheimer-like neuropathology in 5×FAD mice

  2024cites this paper
• RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease

  2024cites this paper
• The Role of the Integrated Stress Response (ISR) in Neuropsychiatric Disorders

  2024cites this paper
• Steroidogenic Acute Regulatory Protein Mediated Variations of Gender-Specific Sex Neurosteroids in Alzheimer's Disease: Relevance to Hormonal Imbalance.

  2024cites this paper
• The protective effects of gastrodin on neurological disorders: an update and future perspectives

  2024cites this paper
• Glucose hypometabolism prompts RAN translation and exacerbates C9orf72-related ALS/FTD phenotypes

  2024cites this paper
• Role of the integrated stress response system (ISR) in neuropsychiatric pathologies of the central nervous system

  2024cites this paper
• Suppression of the amyloidogenic metabolism of APP and the accumulation of Aβ by alcadein α in the brain during aging

  2024cites this paper
• Dysregulated proteostasis network in neuronal diseases

  2023cites this paper
• Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11

  2023cites this paper
• Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases

  2023cites this paper
• The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies

  2023cites this paper
• The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer.

  2023cites this paper
• Nicotinic acetylcholine receptor activation induces BACE1 transcription via the phosphorylation and stabilization of nuclear SP1.

  2023cites this paper
• The potential roles of ATF family in the treatment of Alzheimer's disease.

  2023cites this paper
• Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis in Alzheimer’s disease models

  2023cites this paper
• ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer’s Disease

  2023cites this paper
• Low glucose induced Alzheimer's disease‐like biochemical changes in human induced pluripotent stem cell‐derived neurons is due to dysregulated O‐GlcNAcylation

  2023cites this paper
• Glucose Hypometabolism Prompts RAN Translation and Exacerbates C9orf72-related ALS/FTD Phenotypes

  2023cites this paper
• Messenger RNA Translation Defects in Neurodegenerative Diseases.

  2023cites this paper
• Evidence of Disturbed Insulin Signaling in Animal Models of Alzheimer's Disease.

  2023cites this paper
• Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?

  2023cites this paper
• Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity

  2023cites this paper
• GADD34 suppresses eIF2α phosphorylation and improves cognitive function in Alzheimer's disease-model mice.

  2023cites this paper
• The PPP1R15 Family of eIF2-alpha Phosphatase Targeting Subunits (GADD34 and CReP)

  2023cites this paper
• Effect of arctigenin on neurological diseases: A review.

  2023cites this paper
• Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease

  2023cites this paper
• Why Is Iron Deficiency/Anemia Linked to Alzheimer’s Disease and Its Comorbidities, and How Is It Prevented?

  2023cites this paper
• Ser/Thr phosphatases: One of the key regulators of insulin signaling

  2022cites this paper
• Exogenous Ketones and Lactate as a Potential Therapeutic Intervention for Brain Injury and Neurodegenerative Conditions

  2022cites this paper
• Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer’s disease

  2022cites this paper
• Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer’s Disease Patients

  2022cites this paper
• ABCA7, a Genetic Risk Factor Associated with Alzheimer’s Disease Risk in African Americans

  2022cites this paper
• A Pipeline for Natural Small Molecule Inhibitors of Endoplasmic Reticulum Stress

  2022cites this paper
• Sleep deficiency as a driver of cellular stress and damage in neurological disorders

  2022cites this paper
• Integrated Stress Response in Neuronal Pathology and in Health

  2022cites this paper
• Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease

  2022cites this paper
• Oligomannose-Type Glycan Processing in the Endoplasmic Reticulum and Its Importance in Misfolding Diseases

  2022cites this paper
• Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusion

  2022cites this paper
• USP25 inhibition ameliorates Alzheimer’s pathology through the regulation of APP processing and Aβ generation

  2022cites this paper
• Endoplasmic Reticulum Stress-Associated Neuronal Death and Innate Immune Response in Neurological Diseases

  2022cites this paper
• The role of eIF2 phosphorylation in cell and organismal physiology: new roles for well-known actors.

  2022cites this paper
• Inhibitory Effects of Macelignan on Tau Phosphorylation and Aβ Aggregation in the Cell Model of Alzheimer's Disease

  2022cites this paper
• Error-prone protein synthesis recapitulates early symptoms of Alzheimer disease in aging mice.

  2022cites this paper
• Transcriptomic profiling of myeloid cells in Alzheimer’s Disease brain illustrates heterogeneity of microglia endolysosomal subtypes

  2022cites this paper
• AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.

  2022cites this paper
• Behavioral and Molecular Effects of Thapsigargin-Induced Brain ER- Stress: Encompassing Inflammation, MAPK, and Insulin Signaling Pathway

  2022cites this paper
• Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats

  2022cites this paper
• APP Genetic Deficiency Alters Intracellular Ca2+ Homeostasis and Delays Axonal Degeneration in Dorsal Root Ganglion Sensory Neurons

  2022cites this paper
• The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

  2022cites this paper
• Subtype transcriptomic profiling of myeloid cells in Alzheimer Disease brain illustrates the diversity in active microglia phenotypes

  2021influential citation
• Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer’s disease

  2021cites this paper
• Therapeutic Effects of Natural Compounds and Small Molecule Inhibitors Targeting Endoplasmic Reticulum Stress in Alzheimer’s Disease

  2021cites this paper
• Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress

  2021cites this paper
• Does oxidatively damaged DNA drive amyloid-β generation in Alzheimer’s disease? A hypothesis

  2021cites this paper
• Aβ initiates brain hypometabolism, network dysfunction and behavioral abnormalities via NOX2-induced oxidative stress in mice

  2021cites this paper
• Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes

  2021cites this paper
• Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease

  2021cites this paper
• Subtle genomic DNA damage induces intraneuronal production of amyloid‐β (1‐42) by increasing β‐secretase activity

  2021cites this paper
• PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?

  2021cites this paper
• Post-translational modifications: Regulators of neurodegenerative proteinopathies.

  2021cites this paper
• Wnt5a promotes hippocampal postsynaptic development and GluN2B-induced expression via the eIF2α HRI kinase

  2021cites this paper
• The Unfolded Protein Response in the Human Infant Brain and Dysregulation Seen in Sudden Infant Death Syndrome (SIDS)

  2021cites this paper
• GADD34-mediated dephosphorylation of eIF2α facilitates pseudorabies virus replication by maintaining de novo protein synthesis

  2021cites this paper
• The unfolded protein response is activated in the olfactory system in Alzheimer’s disease

  2020cites this paper
• Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases

  2020cites this paper
• β-Oxidation and autophagy are critical energy providers during acute glucose depletion in Saccharomyces cerevisiae

  2020cites this paper
• Exogenous fibroblast growth factor 1 ameliorates diabetes-induced cognitive decline via coordinately regulating PI3K/AKT signaling and PERK signaling

  2020cites this paper
• Proteostasis and Neurodegeneration

  2020cites this paper
• Insulin resistance and Alzheimer’s disease

  2020cites this paper
• Amyloid Beta-Peptide Increases BACE1 Translation through the Phosphorylation of the Eukaryotic Initiation Factor-2α

  2020cites this paper
• Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease

  2020cites this paper
• ER Stress Signaling in Alzheimer's Disease

  2020cites this paper
• Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease

  2020cites this paper
• Inflamation and oxidative stress : The molecular connectivity between insulin resistance, obesity and Alzheimer's disease

  2020cites this paper
• Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation

  2020cites this paper
• The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration.

  2020cites this paper
• The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases

  2020cites this paper
• Carbonyl-protein content increases in brain and blood of female rats after chronic oxycodone treatment

  2020cites this paper
• Aβ initiates brain hypometabolism and network dysfunction via NOX2 activation: a potential onset mechanism of Alzheimer’s disease

  2020cites this paper
• Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease

  2020cites this paper